More and more companies are presently resorting to formulation and delivery to ensure the success of current and new drug products for the Industry. This is due to a general increase in competing firms throughout the clinical research industry, where New Drug Entities have been discovered and the pressure to produce commercial drugs endure. For the progression and success of current drug products and medicines for the pharmaceutical industry, a vast amount of organisations focus on formulation and delivery. It is thought that the above has risen from an increasing amount of clinical research competitors, where new the needs of new commerciall drugs are on the up and where new drug entities continued to be revealed.

World Drug Delivery and Formulation 2010 is an event that is will be held this year for both scientific and business heads currently involved in formulation and development to deliberate the obstacles that they are currently facing.

Scientific and business professionals from the formulation & delivery fields will be able to converse upon industry specific topics, where visitors will have the ability to partake in the assembly of their main area of interest.

The Following topics will be discussed in various sessions:

- Small molecule formulation - enhancing solubility and bioavailability

- Biologic formulation - improving stability and preventing aggregation

- Drug delivery partnerships - evaluating the potential of new drug delivery technologies

The opportunity to attend these sessions and network with like-minded peers during this two day event will provide attendees with priceless information and facts relating to Drug delivery and formulation. The one-on-one meeting programme offers the chance to meet leading specialists and solution providers in drug formulation and delivery, which could provide valuable insight to business owners who are looking improving working processes back on site.

Drug development is increasingly being outsourced to contract providers as pharmaceutical companies are now focusing more and more on R&D and commercialisation.This has been going on for some time now and now CROs are even dealing with promising biotech companies who do not yet have the necessary facilities and this has in turn supplied more business opportunities to the ever-growing pharmaceutical outsourcing industry. For more information: http://www.ddfevent.com.

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment

You must be logged in to post a comment.